More articles from In the Spotlight

TBK1 Activation by VHL Loss in Renal Cell Carcinoma: A Novel HIF-Independent Vulnerability
Ziad Bakouny, David A. Barbie

Cancer Discovery Mar 2020, 10 (3) 348-350; DOI: 10.1158/2159-8290.CD-19-1525
Regulatory T Cells Keep Pancreatic Cancer at Bay
Berk Aykut, Ruonan Chen, George Miller

Cancer Discovery Mar 2020, 10 (3) 345-347; DOI: 10.1158/2159-8290.CD-20-0002
Unraveling the Architecture of Classic Hodgkin Lymphoma One Cell at a Time
Daniel A.C. Fisher, Stephen T. Oh

Cancer Discovery Mar 2020, 10 (3) 342-344; DOI: 10.1158/2159-8290.CD-19-1538
A New Rho(d) Map to Diffuse Gastric Cancer
Dorothy Benton, Jonathan Chernoff

Cancer Discovery Feb 2020, 10 (2) 182-184; DOI: 10.1158/2159-8290.CD-19-1327
Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy
Johannes Menzel, Joshua C. Black

Cancer Discovery Feb 2020, 10 (2) 179-181; DOI: 10.1158/2159-8290.CD-19-1349
Two Worlds Collide: Unraveling the Role of the Immune System in BRAF–MEK Inhibitor Responses
Keiran S.M. Smalley

Cancer Discovery Feb 2020, 10 (2) 176-178; DOI: 10.1158/2159-8290.CD-19-1441
Personalizing KRAS-Mutant Allele–Specific Therapies
Chiara Falcomatà, Günter Schneider, Dieter Saur

Cancer Discovery Jan 2020, 10 (1) 23-25; DOI: 10.1158/2159-8290.CD-19-1261
Lessons from the A2A Adenosine Receptor Antagonist–Enabled Tumor Regression and Survival in Patients with Treatment-Refractory Renal Cell Cancer
Michail V. Sitkovsky

Cancer Discovery Jan 2020, 10 (1) 16-19; DOI: 10.1158/2159-8290.CD-19-1280
Can the Help Match the Hype? KRAS^G12C-Specific Inhibitors and Beyond
Samuel J. Klempner, Aaron N. Hata

Cancer Discovery Jan 2020, 10 (1) 20-22; DOI: 10.1158/2159-8290.CD-19-1255
Malignant Gliomas: Simplifying the Complexity
Howard A. Fine

Cancer Discovery Dec 2019, 9 (12) 1650-1652; DOI: 10.1158/2159-8290.CD-19-1081

Main menu

User menu

Search

More articles from In the Spotlight

Pages

Articles

Info For

About Cancer Discovery